Andreas Rummel
12Patents
7h-index
5Co-inventors
55Inventor score
Filing activity: Sep 6, 2005 → Jul 14, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8476024B2 | Botulinum neurotoxin a protein receptor and uses thereof | Emerging Cross-Sectional Technologies | 30 | Active |
| US8481040B2 | Carrier for targeting nerve cells | Emerging Cross-Sectional Technologies | 14 | Active |
| US8293230B2 | Transport protein which is used to introduce chemical compounds into nerve cells | Emerging Cross-Sectional Technologies | 12 | Active |
| US10266816B2 | Carrier for targeting nerve cells | Emerging Cross-Sectional Technologies | 9 | Active |
| US10087432B2 | Methods for the manufacture of proteolytically processed polypeptides | Emerging Cross-Sectional Technologies | 7 | Active |
| US10883096B2 | Carrier for targeting nerve cells | Emerging Cross-Sectional Technologies | 7 | Active |
| US9234011B2 | Transport protein which is used to introduce chemical compounds into nerve cells | Emerging Cross-Sectional Technologies | 7 | Active |
| US9422344B2 | Transport protein which is used to introduce chemical compounds into nerve cells | Emerging Cross-Sectional Technologies | 4 | Active |
| US9650622B2 | Carrier for targeting nerve cells | Emerging Cross-Sectional Technologies | 4 | Active |
| US10808236B2 | Methods for the manufacture of proteolytically processed polypeptides | Emerging Cross-Sectional Technologies | 4 | Active |
| US9115350B2 | Carrier for targeting nerve cells | Emerging Cross-Sectional Technologies | 3 | Active |
| US11441141B2 | Methods for the manufacture of proteolytically processed polypeptides | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.